Batch details: RC12-A2
Retatrutide 10mg + Cagrilintide 2.5mg is a novel dual-peptide formulation crafted for cutting-edge metabolic research. Each component contributes unique biological mechanisms, creating a powerful research tool for investigating weight regulation, appetite control, and glucose metabolism.
Retatrutide (5mg):
A next-generation investigational peptide that functions as a triple agonist (GLP-1, GIP, and glucagon receptor pathways). Preclinical and early clinical studies suggest potential roles in enhanced energy expenditure, glycemic regulation, and body composition research.
Cagrilintide (5mg):
An amylin analogue studied for its effects on satiety, delayed gastric emptying, and appetite suppression. It has been investigated in combination with incretin-based therapies for synergistic metabolic effects.
Research Applications
This dual-peptide formulation enables researchers to explore:
Weight management and satiety models
Metabolic regulation and energy expenditure
Combination therapy mechanisms involving incretin and amylin pathways
Glucose homeostasis and appetite signaling
Storage & Handling
Store lyophilized peptides at -20°C.
Reconstituted solutions should be used promptly or stored under proper laboratory conditions.
